Sharif Khan, MD
Hematology · Greenville, SCNPI 1184683435
Payments from drug & device makers
Across 170 payments — averaging $10,259 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1.2M
- Janssen Research & Development, LLC$461K
- AbbVie$19K
- Seagen Inc.$19K
- E.r. Squibb & Sons, L.L.C.$7K
- Pfizer$4K
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 33 | $1,228,228 |
| Janssen Research & Development, LLC | 31 | $461,086 |
| AbbVie | 6 | $19,460 |
| Seagen Inc. | 2 | $19,070 |
| E.r. Squibb & Sons, L.L.C. | 7 | $6,630 |
| Pfizer | 4 | $3,835 |
| Gilead(2 entities) | 11 | $824 |
| Adaptive Biotechnologies Corporation | 8 | $673 |
| Incyte Corporation | 6 | $665 |
| GSK | 5 | $478 |
| Johnson & Johnson | 6 | $371 |
| Sanofi | 5 | $303 |
| Kyowa Kirin, Inc. | 3 | $299 |
| Mallinckrodt Hospital Products Inc. | 2 | $257 |
| AstraZeneca | 3 | $240 |
| Jazz Pharmaceuticals Inc. | 2 | $234 |
| Novartis | 7 | $165 |
| Morphosys, US Inc. | 1 | $145 |
| Acrotech Biopharma Inc. | 2 | $137 |
| ADC Therapeutics America, Inc. | 1 | $120 |
| Daiichi Sankyo Inc. | 1 | $119 |
| Mallinckrodt Enterprises LLC | 1 | $112 |
| Servier Pharmaceuticals LLC | 1 | $101 |
| Agios Pharmaceuticals, Inc. | 1 | $98 |
| Taiho Oncology, Inc. | 3 | $52 |
| Genentech USA, Inc. | 3 | $51 |
| Bristol Myers Squibb | 3 | $47 |
| Karyopharm Therapeutics Inc. | 3 | $47 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Bayer | 1 | $22 |
| Secura Bio, Inc. | 1 | $15 |
| Tersera Therapeutics LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Verastem, Inc. | 1 | $12 |
How this compares
Too few hematology providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Greenville
- Samuel SmithGreenville$15
- Praneeth BaratamCharleston$1.9M
- Brian HessCharleston$1.3M
- Hamza HashmiCharleston$694K
- Asim PatiSpartanburg$324K
- Benjamin DjulbegovicCharleston$225K
- Christopher RangelCharleston$152K
- Charles GreenbergCharleston$26K
- Jailan OsmanColumbia$440
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.